HCPCS Code Descriptor:
Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Route of Administration:
VYXEOS is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9153 is aligned to the drug VYXEOS.